Intuit Announces 3000 Job Cuts in Major AI Restructuring Ladder Capital LADR Surges 070 Nearing 1051 Resistance 20260520 Editas Medicine EDIT Q1 2026 Earnings Roar 026 EPS Tops Street View 36Kr KRKR Q1 2023 Results Holding the Line at 085 Malaysian Startup Eyes Commercialization of LabGrown Unagi Indias Job Engine Strains as Iran Conflict Hits Remittances and Trade Barclays Reports 18 Profit Increase and Lifts FullYear Income Forecast China Tightens Regulations on CrossBorder Stock Trading Key Points Diversified Energy Expands Permian Footprint With Maverick Natural Resources Acquisition LongTerm AI Investment Potential A Stock to Watch Over the Next Decade INDV Q1 2026 Earnings Strong EPS Beat Underscores Operational Discipline CMMB Q1 2026 Earnings Missed EPS Estimates but Stock Gains on Continued Pipeline Progress FSS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction YETI Q1 2026 Earnings Strong Profit Beat Drives Shares Higher AMSF Q1 2026 Earnings EPS Misses Estimates as Stock Declines Summit Hotel Properties Inc INN Q1 2026 Earnings Narrower Loss Beats Estimates Amid Hotel Sector Recovery United Parks Resorts PRKS Surges 36 as Stock Approaches Key Resistance General Purpose Acquisition Corp Units GPACU Holds Steady Near NAV Amid Market Uncertainty Cayson Acquisition Corp CAPN Rises 204 Approaching Key Resistance at 1155 Nova Minerals Limited Warrant NVAWW Holds Steady at 270 Amid Quiet Trading A Paradise Acquisition Corp Unit APADU Holds Steady at 100 Amid Neutral Trading XPO Q1 2026 Earnings EPS Beats Estimates by 14 but Stock Falls on Revenue Concerns NTCT Q1 2026 Earnings EPS Surpasses Expectations Shares Rally Toro Company Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency MSM Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment BX Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline CAI Earnings Overview 20260527 Aequs Reports 33 Revenue Growth in FY26 but Losses Widen Amid Consumer Electronics Expansion Loop Industries Q1 2026 Earnings Narrowerthanexpected loss amid steady technology development Sarepta Therapeutics SRPT Edges Higher Amid Modest Gains